MCHI vs KURE
YTDYear to date
KURE wins+19.7 pts
Past year
KURE wins+14.8 pts
Fee
MCHI winslower fee
Yield
KURE wins+1.9 pts
AUM
MCHI51.4× more
3–1KURE wins
MCHI and KURE · year-to-date · as of Nov 4, 2026 · AUM not scored
KURE vs S&P 500
1Y$17.47 · +0.7% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ S&P 500+ Add a fund
Return1D1M3MYTD1Y ▼3Y5YMAX
Total return+0.7%−9.4%+0.7%+2.5%−6.0%+4.4%−41.2%−13.8%
Peer average−0.3%−7.9%−14.7%−14.9%−17.5%+20.6%−28.2%—
S&P 500 · VOO+0.3%−2.6%−1.7%+11.5%+11.9%+90.9%+77.5%+816.4%
KraneShares KURE and Vanguard VOO · total return, dividends in · as of Nov 4, 2026
KURE’s Holdings
Today6160.HKBeone Medicines8.9%1801.HK8.0%2269.HK7.3%603259.SS5.5%600276.SS4.8%300760.SZ4.6%9926.HK3.9%1177.HK3.6%1093.HK3.4%2359.HK3.1%1548.HK3.0%3692.HK3.0%000538.SZ2.6%688271.SS2.5%300015.SZ2.1%6990.HK2.0%1530.HK2.0%600436.SS2.0%002422.SZ1.8%300759.SZ1.7%1099.HK1.6%31 more
6160.HKBeone Medicines8.9%1801.HK8.0%2269.HK7.3%603259.SS5.5%600276.SS4.8%300760.SZ4.6%9926.HK3.9%1177.HK3.6%1093.HK3.4%2359.HK3.1%1548.HK3.0%41 more
BiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - PharmaceuticalsOther
KraneShares KURE · 53 holdings · tile size = share of the fund · as of Nov 3, 2026
All 25 China ETFs
1Y| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | MCHI | MSCI ChinaReadDesk | 0.59% | 2.2% | −17.2% | −20.8% | $5.5B | |
| 2 | KWEB | KraneShares CSI China InternetReadDesk | 0.69% | 9.0% | −31.6% | −38.2% | $4.3B | |
| 3 | FXI | China Large-CapReadDesk | 0.73% | 2.0% | −12.7% | −14.9% | $3.8B | |
| 4 | CQQQ | China TechnologyReadDesk | 0.65% | 3.0% | −27.3% | −31.1% | $1.8B | |
| 5 | ASHR | Xtrackers Harvest CSI 300 China A-ReadDesk | 0.65% | 2.5% | −7.9% | −6.3% | $1.3B | |
| 6 | GXC | State Street SPDR S&P ChinaReadDesk | 0.59% | 2.4% | −15.4% | −18.6% | $427M | |
| 7 | CXSE | WisdomTree China ex-State-Owned EnterprisesReadDesk | 0.32% | 2.2% | −21.1% | −24.7% | $372M | |
| 8 | FLCH | Franklin FTSE ChinaReadDesk | 0.19% | 2.6% | −17.1% | −20.3% | $256M | |
| 9 | CNYA | MSCI China AReadDesk | 0.60% | 2.1% | −11.6% | −9.4% | $158M | |
| 10 | KURE | KraneShares MSCI All China Health CareReadDesk | 0.79% | 4.1% | +2.5% | −6.0% | $108M | |
| 11 | KBA | KraneShares Bosera MSCI China A 50 ConnectReadDesk | 0.79% | 1.7% | −8.7% | −5.4% | $105M | |
| 12 | CHIQ | Global X - MSCI China Consumer DiscretionaryReadDesk | 0.65% | 1.8% | −24.7% | −29.9% | $98.8M | |
| 13 | PGJ | Golden Dragon ChinaReadDesk | 0.70% | 2.0% | −25.1% | −31.8% | $77.7M | |
| 14 | ECNS | MSCI China Small-CapReadDesk | 0.59% | 7.5% | −21.2% | −25.7% | $56.1M | |
| 15 | CNQQ | Rayliant-ChinaAMC Transformative China TechReadDesk | 0.75% | 0.5% | −21.7% | −24.9% | $43.8M | |
| 16 | KGRN | KraneShares MSCI China Clean TechnologyReadDesk | 0.79% | 1.1% | −20.6% | −28.6% | $42.4M |
1–16 of 25Page 1 of 2
China · current AUM · as of Nov 4, 2026
KURE Payouts by Year
8YLatest payout, Dec 2025
$0.71
a share · once a year
4.1% yield
4.1% yield
8 years added up
$5.21 a share
$5.21 a share
KraneShares KURE · per-share distributions by ex-date · 2018–2025
KURE’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | MCHI | iShares MSCI China ETFReadVersus | 0.59% | 2.2% | −0.4% | −17.2% | −20.8% | $5.5B | |
| 2 | KWEB | KraneShares CSI China Internet ETFReadVersus | 0.69% | 9.0% | −0.3% | −31.6% | −38.2% | $4.3B | |
| 3 | FXI | iShares China Large-Cap ETFReadVersus | 0.73% | 2.0% | −0.1% | −12.7% | −14.9% | $3.8B | |
| 4 | CQQQ | Invesco China Technology ETFReadVersus | 0.65% | 3.0% | −1.8% | −27.3% | −31.1% | $1.8B | |
| 5 | ASHR | Xtrackers Harvest CSI 300 China A-Shares ETFReadVersus | 0.65% | 2.5% | +0.2% | −7.9% | −6.3% | $1.3B | |
| 6 | KURE | KraneShares MSCI All China Health Care Index ETFThis fund | 0.79% | 4.1% | +0.7% | +2.5% | −6.0% | $108M |
#3 of 25 this year · #18 cheapest of 25 · sorted by assetsOpen the Thematic table →
KURE and its peer group · total return · as of Nov 4, 2026
Cards for This View
KURE’s Top 10 Holdings
Today53.0%of KURE sits in these 10
16160.HBeone Medicines8.92%
21801.HInnovent Biologics7.97%
32269.HWuxi Biologics Cayman7.28%
4603259Wuxi Apptec -A5.47%
5600276Jiangsu Hengrui Pharmaceut-A4.79%
6300760Shenzhen Mindray Bio-Medic-A4.62%
79926.HAkeso3.90%
81177.HSino Biopharmaceutical3.62%
91093.HCspc Pharmaceutical Group Lt3.39%
102359.HWuxi Apptec -H3.08%
KraneShares KURE · weight in the fund · as of Nov 3, 2026
KURE’s Holdings
Today6160.HKBeone Medicines8.9%1801.HK8.0%2269.HK7.3%603259.SS5.5%600276.SS4.8%300760.SZ4.6%9926.HK3.9%1177.HK3.6%1093.HK3.4%2359.HK3.1%1548.HK3.0%3692.HK3.0%000538.SZ2.6%688271.SS2.5%300015.SZ2.1%6990.HK2.0%1530.HK2.0%600436.SS2.0%002422.SZ1.8%300759.SZ1.7%1099.HK1.6%31 more
6160.HKBeone Medicines8.9%1801.HK8.0%2269.HK7.3%603259.SS5.5%600276.SS4.8%300760.SZ4.6%9926.HK3.9%1177.HK3.6%1093.HK3.4%2359.HK3.1%1548.HK3.0%41 more
BiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - PharmaceuticalsOther
KraneShares KURE · 53 holdings · tile size = share of the fund · as of Nov 3, 2026
KURE vs Peer Average
YTDKUREAvsBPeer average
1D+0.7%−0.3%
1M−9.4%−7.9%
3M+0.7%−14.7%
YTD+2.5%−14.9%
1Y−6.0%−17.5%
3Y+4.4%+20.6%
5Y−41.2%−28.2%
4–3KURE wins
24 China peers · each row scaled to its leader